Estimates of implantable cardioverter-defibrillator Complications caveat emptor

Circulation

Volumn 119, Issue 8, 2009, Pages 1069-1071

  Anderson, Kelley P ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Arrhythmia; Defibrillation; Editorials; Fibrillation

Indexed keywords

ACCURACY; ASYSTOLE; COMORBIDITY; DEATH; DEFIBRILLATOR; EDITORIAL; FOLLOW UP; HEALTH SERVICE; HEART PROARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MEDICAID; MEDICARE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; SUDDEN DEATH; REGISTER; RISK FACTOR; STANDARD; STATISTICS;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; REGISTRIES; RISK FACTORS;

EID: 62649085139     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.841452     Document Type: Editorial

References (12)

1. Sharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN, Hayes JH, Vidaillet H. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second Multicenter Automatic Defibrillator Implantation Trial. J Interv Card Electrophysiol. 2007; 19:157-164.
2. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA; the National Cardiovascular Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078-1084.
3. Al-Khatib SM, Wang Y, Zareba W, Peterson E, Sanders GD, Krumholz H, Lee KL, Mark DB, Moss AJ. Patients who receive an implantable cardioverter defibrillator for MADIT-II criteria in clinical practice are different from patients enrolled in MADIT-II. Circulation. 2007; 116(suppl II):II-533. Abstract.
4. Al-Khatib SM, Wang Y, Lee KL, Mark DB, Poole JE, Sanders GD, Peterson E, Curtis J, Bardy GH. Do patients who meet SCD-HeFT criteria in clinical practice differ from patients enrolled in SCD-HeFT? Circulation. 2007;116(suppl II):II-822. Abstract.
5. Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm. 2008;5:1359-1363.
6. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-262.
7. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493-2497.
8. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care. 2002;40: 675-685.
9. Gibbs JL, Monro JL, Cunningham D, Rickards A; Society of Cardiothoracic Surgeons of Great Britain and Northern Ireland; Paediatric Cardiac Association; Alder Hey Hospital. Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000-1. BMJ. 2004;328:611.
10. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol. 2006;29:614-618.
11. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J lnterv Card Electrophysiol. 2005;14:71-78.
12. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-1261.